세계의 바이오테크 협력 시장 보고서(2025년)

Biotech collaborations refer to strategic partnerships between biotechnology companies, research institutions, or other organizations aimed at jointly developing, researching, or commercializing biotechnological products and innovations. These collaborations facilitate the sharing of expertise, resources, and technologies to accelerate innovation, reduce risks, and bring advanced biotech solutions to market more efficiently.

The primary types of biotech collaborations are research and development collaborations, licensing agreements, joint ventures, mergers or acquisitions, and others. Research and development collaborations involve strategic partnerships between two or more organizations to jointly conduct scientific research and develop new products, technologies, or processes. These collaborations support applications such as drug discovery, clinical research, diagnostics, therapeutics, and others, and serve end users including pharmaceutical companies, biotechnology firms, academic and research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The biotech collaborations market research report is one of a series of new reports from The Business Research Company that provides biotech collaborations market statistics, including biotech collaborations industry global market size, regional shares, competitors with a biotech collaborations market share, detailed biotech collaborations market segments, market trends and opportunities, and any further data you may need to thrive in the biotech collaborations industry. This biotech collaborations market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biotech collaborations market size has grown rapidly in recent years. It will grow from $84.59 billion in 2024 to $94.35 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth during the historic period was driven by increasing demand for novel therapeutics, rising research and development expenditure, growing prevalence of chronic diseases, expanding regulatory complexities, and higher adoption of advanced biotechnologies.

The biotech collaborations market size is expected to see rapid growth in the next few years. It will grow to $144.06 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth during the forecast period is fueled by growing investments in biotech startups, rising demand for sustainable and green bioprocesses, increased focus on personalized medicine, expanding adoption of gene and cell therapies, and a growing need for cost optimization. The primary trends in the forecast period include development of next-generation biologics, integration of omics data, incorporation of digital health technologies, innovation in drug delivery systems, and advancement of sustainable bioprocesses.

The growing demand for personalized medicine is expected to drive the expansion of the biotech collaborations market in the coming years. Personalized medicine tailors treatment and prevention strategies to an individual's unique genetic profile, lifestyle, and environment. This surge in personalized medicine adoption is largely due to advancements in genomics, which allow for the precise identification of genetic variations and the development of tailored treatments. Biotech collaborations play a crucial role in this progress by combining expertise and innovative technologies, accelerating the development of targeted therapies for individual patients. These collaborations reduce research timelines and improve the success rates of new treatments, enhancing both efficacy and patient outcomes. For example, in February 2024, the Personalized Medicine Coalition (PMC) reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant rise from the 12 approved in 2022. As a result, the demand for personalized medicine is driving growth in the biotech collaborations market.

Companies in the biotech collaborations market are focusing on developing innovative solutions, such as artificial intelligence (AI)-driven drug discovery platforms, to accelerate the identification of new therapeutics and improve research and development efficiency. AI-driven drug discovery platforms leverage advanced algorithms and machine learning to analyze biological data, predict drug-target interactions, and streamline the development of new treatments. For instance, in January 2025, Iktos S.A.S., a France-based biotechnology company, partnered with Cube Biotech GmbH, a Germany-based biotech company, to develop novel small molecule agonists targeting the amylin receptor, a promising therapeutic target for cardiometabolic disorders, including obesity, diabetes, and metabolic dysfunction-associated steatotic hepatitis (MASH). This collaboration combines Iktos' generative AI-driven drug discovery platform with Cube Biotech's expertise in membrane protein technology and protein stabilization methods. The partnership aims to accelerate drug discovery timelines, enhance success rates, and improve targeting of challenging membrane proteins, offering potential therapies that could be more efficient and cost-effective than current treatments, such as GLP-1 receptor agonists.

In December 2023, Pfizer Inc., a U.S.-based pharmaceutical company, acquired Seagen Inc. for $43 billion. This acquisition strengthens Pfizer's oncology portfolio, expands its pipeline of targeted cancer therapies, and positions the company for long-term growth in the oncology space. Seagen, a biopharmaceutical company based in the U.S., has established strategic collaborations to advance its oncology pipeline.

Major players in the biotech collaborations market are Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, AstraZeneca plc, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Eli Lilly And Company, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited, Amgen Inc., Gilead Sciences Inc., C.H. Boehringer Sohn AG & Co. KG, CSL Limited., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, and Biogen Inc.

North America was the largest region in the biotech collaborations market in 2024. The regions covered in biotech collaborations report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biotech collaborations market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biotech collaborations market includes revenues earned by entities through clinical trial services, licensing and technology transfer, manufacturing and contract development, regulatory and consulting services, and bioinformatics and data analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biotech Collaborations Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biotech collaborations market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biotech collaborations ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biotech collaborations market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Collaboration Type: Research And Development Collaborations; Licensing Agreements; Joint Ventures; Mergers Or Acquisitions; Other Collaborations
• 2) By Application: Drug Discovery; Clinical Research; Diagnostics; Therapeutics; Other Applications
• 3) By End User: Pharmaceutical Companies; Biotechnology Firms; Academic And Research Institutes; Other End-Users
• Subsegments:
• 1) By Research And Development Collaborations: Preclinical Research; Clinical Trials; Translational Research; Drug Discovery
• 2) By Licensing Agreements: Exclusive Licensing; Non Exclusive Licensing; In Licensing; Out Licensing
• 3) By Joint Ventures: Strategic Alliance; Co Development; Co Marketing; Technology Sharing
• 4) By Mergers Or Acquisitions: Horizontal Merger; Vertical Merger; Conglomerate Merger; Acquisition Of Assets
• 5) By Other Collaborations: Research Consortium; Public Private Partnership; Academic Collaboration; Contract Research
• Companies Mentioned: Johnson And Johnson; F. Hoffmann-La Roche Ltd.; Merck And Co. Inc.; Pfizer Inc.; AbbVie Inc.; Bayer AG; Sanofi S.A.; Novartis AG; AstraZeneca plc; Bristol-Myers Squibb Company; GlaxoSmithKline plc; Eli Lilly And Company; Novo Nordisk A/S; Takeda Pharmaceutical Company Limited; Amgen Inc.; Gilead Sciences Inc.; C.H. Boehringer Sohn AG & Co. KG; CSL Limited.; Regeneron Pharmaceuticals Inc.; Vertex Pharmaceuticals Incorporated; Biogen Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biotech Collaborations Market Characteristics

3. Biotech Collaborations Market Trends And Strategies

4. Biotech Collaborations Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biotech Collaborations Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biotech Collaborations PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biotech Collaborations Market Growth Rate Analysis
• 5.4. Global Biotech Collaborations Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biotech Collaborations Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biotech Collaborations Total Addressable Market (TAM)

6. Biotech Collaborations Market Segmentation

• 6.1. Global Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research And Development Collaborations
• Licensing Agreements
• Joint Ventures
• Mergers Or Acquisitions
• Other Collaborations
• 6.2. Global Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery
• Clinical Research
• Diagnostics
• Therapeutics
• Other Applications
• 6.3. Global Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Biotechnology Firms
• Academic And Research Institutes
• Other End-Users
• 6.4. Global Biotech Collaborations Market, Sub-Segmentation Of Research And Development Collaborations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preclinical Research
• Clinical Trials
• Translational Research
• Drug Discovery
• 6.5. Global Biotech Collaborations Market, Sub-Segmentation Of Licensing Agreements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Exclusive Licensing
• Non Exclusive Licensing
• In Licensing
• Out Licensing
• 6.6. Global Biotech Collaborations Market, Sub-Segmentation Of Joint Ventures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Strategic Alliance
• Co Development
• Co Marketing
• Technology Sharing
• 6.7. Global Biotech Collaborations Market, Sub-Segmentation Of Mergers Or Acquisitions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Horizontal Merger
• Vertical Merger
• Conglomerate Merger
• Acquisition Of Assets
• 6.8. Global Biotech Collaborations Market, Sub-Segmentation Of Other Collaborations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research Consortium
• Public Private Partnership
• Academic Collaboration
• Contract Research

7. Biotech Collaborations Market Regional And Country Analysis

• 7.1. Global Biotech Collaborations Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biotech Collaborations Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biotech Collaborations Market

• 8.1. Asia-Pacific Biotech Collaborations Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biotech Collaborations Market

• 9.1. China Biotech Collaborations Market Overview
• 9.2. China Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biotech Collaborations Market

• 10.1. India Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biotech Collaborations Market

• 11.1. Japan Biotech Collaborations Market Overview
• 11.2. Japan Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biotech Collaborations Market

• 12.1. Australia Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biotech Collaborations Market

• 13.1. Indonesia Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biotech Collaborations Market

• 14.1. South Korea Biotech Collaborations Market Overview
• 14.2. South Korea Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biotech Collaborations Market

• 15.1. Western Europe Biotech Collaborations Market Overview
• 15.2. Western Europe Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biotech Collaborations Market

• 16.1. UK Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biotech Collaborations Market

• 17.1. Germany Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biotech Collaborations Market

• 18.1. France Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biotech Collaborations Market

• 19.1. Italy Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biotech Collaborations Market

• 20.1. Spain Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biotech Collaborations Market

• 21.1. Eastern Europe Biotech Collaborations Market Overview
• 21.2. Eastern Europe Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biotech Collaborations Market

• 22.1. Russia Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biotech Collaborations Market

• 23.1. North America Biotech Collaborations Market Overview
• 23.2. North America Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biotech Collaborations Market

• 24.1. USA Biotech Collaborations Market Overview
• 24.2. USA Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biotech Collaborations Market

• 25.1. Canada Biotech Collaborations Market Overview
• 25.2. Canada Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biotech Collaborations Market

• 26.1. South America Biotech Collaborations Market Overview
• 26.2. South America Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biotech Collaborations Market

• 27.1. Brazil Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biotech Collaborations Market

• 28.1. Middle East Biotech Collaborations Market Overview
• 28.2. Middle East Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biotech Collaborations Market

• 29.1. Africa Biotech Collaborations Market Overview
• 29.2. Africa Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biotech Collaborations Market Competitive Landscape And Company Profiles

• 30.1. Biotech Collaborations Market Competitive Landscape
• 30.2. Biotech Collaborations Market Company Profiles
  • 30.2.1. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Biotech Collaborations Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi S.A.
• 31.3. Novartis AG
• 31.4. AstraZeneca plc
• 31.5. Bristol-Myers Squibb Company
• 31.6. GlaxoSmithKline plc
• 31.7. Eli Lilly And Company
• 31.8. Novo Nordisk A/S
• 31.9. Takeda Pharmaceutical Company Limited
• 31.10. Amgen Inc.
• 31.11. Gilead Sciences Inc.
• 31.12. C.H. Boehringer Sohn AG & Co. KG
• 31.13. CSL Limited.
• 31.14. Regeneron Pharmaceuticals Inc.
• 31.15. Vertex Pharmaceuticals Incorporated

32. Global Biotech Collaborations Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biotech Collaborations Market

34. Recent Developments In The Biotech Collaborations Market

35. Biotech Collaborations Market High Potential Countries, Segments and Strategies

• 35.1 Biotech Collaborations Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biotech Collaborations Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biotech Collaborations Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer